0001237899-13-000032.txt : 20130509
0001237899-13-000032.hdr.sgml : 20130509
20130509165935
ACCESSION NUMBER: 0001237899-13-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130507
FILED AS OF DATE: 20130509
DATE AS OF CHANGE: 20130509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Terifay Robert J
CENTRAL INDEX KEY: 0001391382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13829724
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-05-07
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001391382
Terifay Robert J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Commercial
Common Stock
2013-05-07
4
M
0
14750.0
16.8
A
30074
D
Common Stock
2013-05-07
4
F
0
946.0
261.67
D
29128
D
Common Stock
2013-05-07
4
F
0
6857.0
261.67
D
22271
D
Common Stock
2013-05-07
4
M
0
2173.0
16.8
A
24444
D
Common Stock
2013-05-07
4
F
0
139.0
261.67
D
24305
D
Common Stock
2013-05-07
4
F
0
750.0
261.67
D
23555
D
Common Stock
2013-05-08
4
S
0
3394.0
260.86
D
20161
D
Common Stock
2013-05-08
4
S
0
4437.0
261.44
D
15724
D
Common Stock
2013-05-08
4
S
0
400.0
262.06
D
15324
D
Common Stock
1588
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
16.8
2013-05-07
4
M
0
14750.0
D
2011-12-31
2018-12-17
Common Stock
14750
2173
D
Non-Qualified Stock Option (right to buy)
16.8
2013-05-07
4
M
0
2173.0
D
2018-12-17
Common Stock
2173
0
D
Represents volume-weighted average price of sales of 3,394 shares of Company stock on May 8, 2013 at prices ranging from $260.58 to $260.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
Represents volume-weighted average price of sales of 4,437 shares of Company stock on May 8, 2013 at prices ranging from $261.01 to $261.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
Represents volume-weighted average price of sales of 400 shares of Company stock on May 8, 2013 at prices ranging from $262.03 to $262.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price.
On December 17, 2008, the reporting person was granted an option to purchase 48,750 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
/s/**Robert J. Terifay
2013-05-09